Galmed Pharmaceuticals (GLMD) Interest Coverage Ratio (2014 - 2020)
Galmed Pharmaceuticals (GLMD) recorded quarterly Interest Coverage Ratio of 16.2 in Q1 2020, down 119.68% quarter-over-quarter from 7.37 in Q1 2019, and down 119.68% on a YoY basis from 82.29 in Q2 2019.
Galmed Pharmaceuticals (GLMD) Interest Coverage Ratio (2014 - 2020) Analysis & Trends
Galmed Pharmaceuticals' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 16.2 for Q1 2020.
- In Q1 2020, Interest Coverage Ratio fell 119.68% year-over-year to 16.2; the TTM figure through Mar 2020 stood at 58.4 (down 399.1% YoY), while the FY2021 annual figure was 649.33, up 482.95% from the prior year.
- Interest Coverage Ratio was 16.2 for Q1 2020 at Galmed Pharmaceuticals, down from 7.37 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 67.11 in Q4 2016 to a low of 298.11 in Q2 2017.
- Historically, Interest Coverage Ratio has averaged 28.3 across 5 years, with a median of 22.51 in 2018.
- The sharpest annual moves came in 2016 and 2017: Interest Coverage Ratio soared 428.18% in 2016, then slumped 728.57% in 2017.
- A 5-year view of Interest Coverage Ratio shows it stood at 67.11 in 2016, then slipped by 7.78% to 61.89 in 2017, then slumped by 103.21% to 1.99 in 2018, then tumbled by 271.12% to 7.37 in 2019, then plunged by 119.68% to 16.2 in 2020.
- The last three Interest Coverage Ratio figures came in at 16.2 (Q1 2020), 7.37 (Q1 2019), and 1.99 (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -16.20 |
| Mar 31, 2019 | -7.37 |
| Sep 30, 2018 | -1.99 |
| Jun 30, 2018 | -28.83 |
| Mar 31, 2018 | -48.28 |
| Sep 30, 2017 | 61.89 |
| Jun 30, 2017 | -298.11 |
| Mar 31, 2017 | -32.00 |
| Dec 31, 2016 | 67.11 |
| Sep 30, 2016 | -48.78 |
| Jun 30, 2016 | 47.43 |
| Mar 31, 2016 | -34.48 |
| Sep 30, 2015 | 24.24 |
| Jun 30, 2015 | -14.45 |
| Mar 31, 2015 | -61.07 |
| Sep 30, 2014 | 199.38 |
| Jun 30, 2014 | -293.83 |
| Mar 31, 2014 | 82.12 |